The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real‐world data in Israel

por Melzer Cohen, Cheli, Banon, Tamar, Shalev, Varda, Chodick, Gabriel
Publicado en Endocrinol Diabetes Metab (2020)

Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting

por Melzer-Cohen, Cheli, Chodick, Gabriel, Naftelberg, Shiran, Shehadeh, Naim, Karasik, Avraham
Publicado en Diabetes Ther (2019)

Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Co...

por Melzer Cohen, Cheli, Thorsted, Brian Larsen, Wolden, Michael Lyng, Chodick, Gabriel, Karasik, Avraham
Publicado en Diabetes Ther (2017)

Anxiolytic treatment but not anxiety itself causes hyponatremia among anxious patients

por Gilboa, Mayan, Koren, Gideon, Katz, Racheli, Melzer-Cohen, Cheli, Shalev, Varda, Grossman, Ehud
Publicado en Medicine (Baltimore) (2019)

A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes

por Melzer-Cohen, Cheli, Chodick, Gabriel, Husemoen, Lise Lotte N., Rhee, Nicolai, Shalev, Varda, Karasik, Avraham
Publicado en Diabetes Ther (2019)

Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL...

por Lam, Carolyn S. P., Karasik, Avraham, Melzer‐Cohen, Cheli, Cavender, Matthew A., Kohsaka, Shun, Norhammar, Anna, Thuresson, Marcus, Chen, Hungta, Wittbrodt, Eric, Fenici, Peter, Kosiborod, Mikhail
Publicado en Diabetes Obes Metab (2021)